Fintech and technology startups have continued to see their coffers grow

SoftBank helped e-commerce brand aggregator Merama hike its series B round to $285m while Koch Industries took part in a round valuing supply chain finance provider Tradeshift at $2.7bn.

Cerebral, Robotic Research, ABclonal Technology, Ola and RainMed Medical all pulled in nine-figure rounds, the first two featuring SoftBank Vision Fund 2.

Q&A with John Banta, president and managing director, Blue Venture Fund

The cancer diagnostics technology developer raised $300m from investors also including Kaiser Permanente, Intermountain, Novartis and Roche, but its machine learning model points to where GV is increasingly active.

Incode and Odyssey Therapeutics each secured over $200m while Alvotech Holdings, BenevolentAI and Tomorrow.io have agreed reverse mergers at unicorn valuations.

Professional education provider Platzi pulled in $60m through a Prosus-led round while e-commerce software producer Marketplacer took in $38m from investors including Salesforce Ventures.

SoftBank’s Latin America Fund helped prayer app developer Glorify raise $40m at a $250m valuation while decentralised derivatives network Hxro Network secured $34m in a round featuring several corporates.

AviadoBio is focusing on neurodegenerative diseases and has emerged from stealth with nearly $100m in total from investors including Johnson & Johnson Innovation – JJDC.

Access Industries subsidiary Access Biotechnology co-led a round disclosed by the radiopharmaceutical drug developer as it publicly launched.